Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 58

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model

Diaz-Perdigon, Teresa, Belloch, Francisco B., Ricobaraza, Ana, Elboray, Elghareeb E., Suzuki, Takayoshi, Tordera, Rosa M., Puerta, Elena · 2020 · Neuropsychopharmacology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41386-019-0503-8

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 65

  1. Akbarian S, Beeri MS, Haroutunian V. Epigenetic determinants of healthy and diseased brain aging and cognition. JAMA Neurol 2013;70:711–8. · DOI
  2. Brunet A, Berger SL. Epigenetics of aging and aging-related disease. J Gerontol Ser A Biol Sci Med Sci 2014;69:S17–20. · DOI · Paper page
  3. Guzman-Martinez L, Maccioni RB, Farías GA, Fuentes P, Navarrete LP. Biomarkers for Alzheimer’s disease. Curr Alzheimer Res. 2019;16;518–28. · DOI · Paper page
  4. Gräff J, Tsai L-H. The potential of HDAC inhibitors as cognitive enhancers. Annu Rev Pharm Toxicol 2013;53:311–30. · DOI · Paper page
  5. Sharma M, Shetty MS, Arumugam TV, Sajikumar S. Histone deacetylase 3 inhibition re-establishes synaptic tagging and capture in aging through the activation of nuclear factor kappa B. Sci Rep 2015;5:16616.
  6. Mastroeni D, et al. Epigenetic mechanisms in Alzheimer’s disease. Neurobiol Aging 2011;32:1161–80. · DOI · Paper page
  7. Jayasena T, et al. Application of targeted mass spectrometry for the quantification of sirtuins in the central nervous system. Sci Rep 2016;6:35391. · DOI · Paper page
  8. Eskandarian HA, et al. A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection. Science 2013;341:1238858. · DOI · Paper page
  9. Suzuki K, Koike T. Mammalian Sir2-related protein (SIRT) 2–mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation. Neuroscience 2007;147:599–612. · DOI
  10. Pfister JA, Ma C, Morrison BE, D’Mello SR. Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS ONE 2008;3:e4090. · DOI · Paper page
  11. Maxwell MM, et al. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet 2011;20:3986–96. · DOI · Paper page
  12. Anwar T, Khosla S, Ramakrishna G. Increased expression of SIRT2 is a novel marker of cellular senescence and is dependent on wild type p53 status. Cell Cycle 2016;15:1883–97. · DOI
  13. Outeiro TF, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson’s disease. Science 2007;317:516–9. · DOI · Paper page
  14. Chopra V, et al. The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington’s disease mouse models. Cell Rep 2012;2:1492–7. · DOI · Paper page
  15. de Oliveira RM, et al. The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol 2017;15:e2000374. · DOI · Paper page
  16. Erburu M, et al. SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action. Neuropharmacology 2017;117:195–208. · DOI · Paper page
  17. Muñoz-Cobo I, Belloch FB, Díaz-Perdigón T, Puerta E, Tordera RM. SIRT2 inhibition reverses anhedonia in the VGLUT1+/- depression model. Behav Brain Res 2017;335:128–31. · DOI
  18. Polito L, et al. The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease in two Caucasian case-control cohorts. Alzheimers Dement 2013;9:392–9. · DOI
  19. Wei W, et al. The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease: a meta-analysis. Neuromolecular Med 2014;16:448–56. · DOI
  20. Cacabelos R, et al. Sirtuins in Alzheimer’s disease: SIRT2-related genophenotypes and implications for pharmacoepigenetics. Int J Mol Sci 2019;20:1249. · DOI
  21. Spires-Jones TL, et al. Inhibition of sirtuin 2 with sulfobenzoic acid derivative AK1 is non-toxic and potentially neuroprotective in a mouse model of frontotemporal dementia. Front Pharmacol 2012;3:42.
  22. Biella G, et al. Sirtuin 2 inhibition improves cognitive performance and acts on amyloid-β protein precursor processing in two Alzheimer’s disease mouse models. J Alzheimers Dis 2016;53:1193–207. · DOI · Paper page
  23. Silva DF, Esteves AR, Oliveira CR, Cardoso SM. Mitochondrial metabolism power SIRT2-dependent deficient traffic causing Alzheimer’s-disease related pathology. Mol Neurobiol 2017;54:4021–40. · DOI
  24. Esteves AR, et al. Acetylation as a major determinant to microtubule-dependent autophagy: relevance to Alzheimer’s and Parkinson disease pathology. Biochim Biophys Acta. 2018. https://doi.org/10.1016/j.bbadis.2018.11.014 . · DOI · Paper page
  25. Tomobe K, Nomura Y. Neurochemistry, neuropathology, and heredity in SAMP8: a mouse model of senescence. Neurochem Res 2009;34:660–9. · DOI
  26. Pallas M, et al. From aging to Alzheimer’s disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 2008;15:615–24. · DOI · Paper page
  27. Griñán-Ferré C, et al. Understanding epigenetics in the neurodegeneration of Alzheimer’s disease: SAMP8 mouse model. J Alzheimers Dis 2018;62:943–63. · DOI
  28. Cosín-Tomás M, et al. Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise. Front Aging Neurosci 2014;6:51.
  29. Cosín-Tomás M, et al. Temporal integrative analysis of mRNA and microRNAs expression profiles and epigenetic alterations in female SAMP8, a model of age-related cognitive decline. Front Genet 2018;9:596. · DOI
  30. Griñan-Ferré C, et al. Environmental enrichment modified epigenetic mechanisms in SAMP8 mouse hippocampus by reducing oxidative stress and inflammaging and achieving neuroprotection. Front Aging Neurosci 2016;8:241. · DOI
  31. Griñan-Ferré C, et al. Environmental enrichment improves behavior, cognition, and brain functional markers in young senescence-accelerated prone mice (SAMP8). Mol Neurobiol 2016;53:2435–50. · DOI
  32. Suzuki T, et al. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. J Med Chem 2012;55:5760–73. · DOI
  33. Flood JF, Farr SA, Kaiser FE, Morley JE. Age-related impairment in learning but not memory in SAMP8 female mice. Pharm Biochem Behav 1995;50:661–4. · DOI
  34. Orejana L, Barros-Miñones L, Aguirre N, Puerta E. Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model. Exp Gerontol 2013;48:565–71. · DOI
  35. Orejana L, Barros-Miñones L, Jordán J, Puerta E, Aguirre N. Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model. Neurobiol Aging 2012;33:625.e11–20. · DOI
  36. Orejana L, et al. Sildenafil decreases BACE1 and cathepsin B levels and reduces APP amyloidogenic processing in the SAMP8 mouse. J Gerontol Ser A Biol Sci Med Sci 2015;70:675–85. · DOI
  37. García-Osta A, Cuadrado-Tejedor M. Advanced assay monitoring APP-carboxyl-terminal fragments as markers of APP processing in Alzheimer disease mouse models. Methods Mol Biol 2016;1303:117–23. · DOI
  38. Gal J, Bang Y, Choi HJ. SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition. Neurochem Int 2012;61:992–1000. · DOI
  39. Gan L, Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 2008;58:10–14. · DOI · Paper page
  40. Wongchitrat P, et al. Alterations in the expression of amyloid precursor protein cleaving enzymes mRNA in Alzheimer peripheral blood. Curr Alzheimer Res 2018;16:29–38. · DOI
  41. Wloga D, Joachimiak E, Fabczak H. Tubulin post-translational modifications and microtubule dynamics. Int J Mol Sci 2017;18:2207. · DOI · Paper page
  42. Yoo DY, et al. Sodium butyrate, a histone deacetylase Inhibitor, ameliorates SIRT2-induced memory impairment, reduction of cell proliferation, and neuroblast differentiation in the dentate gyrus. Neurol Res 2015;37:69–76. · DOI
  43. Theendakara V, et al. Neuroprotective Sirtuin ratio reversed by ApoE4. Proc Natl Acad Sci USA 2013;110:18303–8. · DOI · Paper page
  44. Porquet D, et al. Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8. Age (Dordr) 2013;35:1851–65. · DOI · Paper page
  45. Zhao Y, et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol 2010;12:665–75. · DOI · Paper page
  46. Inoue T, et al. SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors. FEBS J 2014;281:2623–37. · DOI
  47. Fonseca R. The aging memory: modulating epigenetic modifications to improve cognitive function. Neurobiol Learn Mem 2016;133:182–4. · DOI
  48. Magnusson KR, Nelson SE, Young AB. Age-related changes in the protein expression of subunits of the NMDA receptor. Brain Res Mol Brain Res 2002;99:40–45. · DOI
  49. Brim BL, et al. Memory in aged mice is rescued by enhanced expression of the GluN2B subunit of the NMDA receptor. Behav Brain Res 2013;238:211–26. · DOI
  50. Muñoz-Cobo I, et al. Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers. Psychopharmacology (Berl) 2018;235:2831–46. · DOI
  51. Luo Y, et al. Reversal of aging-related emotional memory deficits by norepinephrine via regulating the stability of surface AMPA receptors. Aging Cell 2015;14:170–9. · DOI
  52. Wang B, et al. SIRT2 plays significant roles in lipopolysaccharides-induced neuroinflammation and brain injury in mice. Neurochem Res 2016;41:2490–2500. · DOI
  53. Moreno LCGEI, et al. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer’s disease. Int J Pharm 2017;517:50–57. · DOI · Paper page
  54. Rancán L, et al. Protective effect of xanthohumol against age-related brain damage. J Nutr Biochem 2017;49:133–40. · DOI
  55. Cheng J, et al. Vitamin D combined with resveratrol prevents cognitive decline in SAMP8 mice. Curr Alzheimer Res 2017;14:820–33. · DOI
  56. Chen Z-J, Yang Y-F, Zhang Y-T, Yang D-H. Dietary total prenylflavonoids from the fruits of Psoralea corylifolia L. prevents age-related cognitive deficits and down-regulates Alzheimer’s markers in SAMP8 mice. Molecules 2018;23:196. · DOI
  57. Scuderi C, et al. Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer’s disease. Front Pharmacol 2014;5:89. · DOI
  58. Lee AS, et al. SIRT2 ameliorates lipopolysaccharide-induced inflammation in macrophages. Biochem Biophys Res Commun 2014;450:1363–9. · DOI
  59. Chen H, Wu D, Ding X, Ying W. SIRT2 is required for lipopolysaccharide-induced activation of BV2 microglia. Neuroreport 2015;26:88–93. · DOI
  60. Zhao T, et al. Selective inhibition of SIRT2 improves outcomes in a lethal septic model. Curr Mol Med 2015;15:634–41. · DOI
  61. Pais TF, et al. The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J 2013;32:2603–16. · DOI · Paper page
  62. Yuan F, et al. SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-κB p65 acetylation and activation. J Neurochem 2016;136:581–93. · DOI
  63. Li Y, et al. SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes Cells 2011;16:34–45. · DOI · Paper page
  64. He X, et al. SIRT2 activity is required for the survival of C6 glioma cells. Biochem Biophys Res Commun 2012;417:468–72. · DOI
  65. Lynn EG, McLeod CJ, Gordon JP, Bao J, Sack MN. SIRT2 is a negative regulator of anoxia-reoxygenation tolerance via regulation of 14-3-3 zeta and BAD in H9c2 cells. FEBS Lett 2008;582:2857–62. · DOI

Cited by

See all 58

Metadata

Authors
Diaz-Perdigon, T., Belloch, F. B., Ricobaraza, A., Elboray, E. E., Suzuki, T., Tordera, R. M., & Puerta, E.
Venue
Neuropsychopharmacology
Published
2019-08-30
Volume
45
Issue
2
Pages
347-357
ISSN
  • 0893-133X
  • 1740-634X
Cited by
58
References
3
Language
en
Licence
Funders
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (SAF2011-27910, SAF2017-87595-R)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model. https://app.cochat.ai/papers/10.1038/s41386-019-0503-8
The paper
Diaz-Perdigon, T., Belloch, F. B., Ricobaraza, A., Elboray, E. E., Suzuki, T., Tordera, R. M., & Puerta, E. (2020). Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model. Neuropsychopharmacology. https://doi.org/10.1038/s41386-019-0503-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.